Literature DB >> 20172613

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Biana Godin1, Jason H Sakamoto, Rita E Serda, Alessandro Grattoni, Ali Bouamrani, Mauro Ferrari.   

Abstract

Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques. Published by Elsevier Ltd.

Entities:  

Mesh：

Year:  2010        PMID： 20172613      PMCID： PMC2862836          DOI： 10.1016/j.tips.2010.01.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


  81 in total

1.  Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species.

Authors:  Y Cui; Q Wei; H Park; C M Lieber
Journal:  Science       Date:  2001-08-17       Impact factor: 47.728

Review 2.  Tiny solutions for giant cardiac problems.

Authors:  David F Kong; Pascal J Goldschmidt-Clermont
Journal:  Trends Cardiovasc Med       Date:  2005-08       Impact factor: 6.677

3.  Nanogeometry: beyond drug delivery.

Authors:  Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03       Impact factor: 39.213

4.  nan'o.tech.nol'o.gy n.

Authors:  Thomas Theis; Doug Parr; Peter Binks; Jackie Ying; K Eric Drexler; Elisabeth Schepers; Kary Mullis; Chunli Bai; John J Boland; Robert Langer; Peter Dobson; C N R Rao; Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2006-10       Impact factor: 39.213

5.  The rational design of nitric oxide selectivity in single-walled carbon nanotube near-infrared fluorescence sensors for biological detection.

Authors:  Jong-Ho Kim; Daniel A Heller; Hong Jin; Paul W Barone; Changsik Song; Jingqing Zhang; Laura J Trudel; Gerald N Wogan; Steven R Tannenbaum; Michael S Strano
Journal:  Nat Chem       Date:  2009-08-24       Impact factor: 24.427

6.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Authors:  Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Christoph Kaiser; Marco Valgimigli; Henning Kelbaek; Maurizio Menichelli; Manel Sabaté; Maarten J Suttorp; Dietrich Baumgart; Melchior Seyfarth; Matthias E Pfisterer; Albert Schömig
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

Review 7.  Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Authors:  Megan M Kaneda; Shelton Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  Ann Biomed Eng       Date:  2009-01-30       Impact factor: 3.934

Review 8.  Delivery of nano-objects to functional sub-domains of healthy and failing cardiac myocytes.

Authors:  Valeriy Lukyanenko
Journal:  Nanomedicine (Lond)       Date:  2007-12       Impact factor: 5.307

9.  HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries.

Authors:  Xinhua Yin; Yu Fu; Chikao Yutani; Yoshihiko Ikeda; Keiichi Enjyoji; Hisao Kato
Journal:  Int J Cardiol       Date:  2008-06-30       Impact factor: 4.164

Review 10.  Nanomedicine for the management of lung and blood diseases.

Authors:  Denis B Buxton
Journal:  Nanomedicine (Lond)       Date:  2009-04       Impact factor: 5.307
View more
  43 in total

1.  In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles.

Authors:  Juliana M Chan; June-Wha Rhee; Chester L Drum; Roderick T Bronson; Gershon Golomb; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-15       Impact factor: 11.205

Review 2.  Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.

Authors:  Sascha N Goonewardena
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

3.  The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.

Authors:  Hua Zhang; Ning Li; Padmini Sirish; Lisa Mahakian; Elizabeth Ingham; Fitz-Roy Curry; Soichiro Yamada; Nipavan Chiamvimonvat; Katherine W Ferrara
Journal:  J Control Release       Date:  2012-07-07       Impact factor: 9.776

Review 4.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Cardiovascular nanomedicine: a posse ad esse.

Authors:  Biana Godin; Mauro Ferrari
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 6.  Towards Precision in HF Pharmacotherapy.

Authors:  Nicholas B Norgard; Carolyn Hempel
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 7.  Informatics and standards for nanomedicine technology.

Authors:  Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-06-30

Review 8.  Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.

Authors:  Jay C Sy; Michael E Davis
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

Review 9.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

10.  Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.

Authors:  Andrzej S Pitek; Slater A Jameson; Frank A Veliz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomaterials       Date:  2016-02-23       Impact factor: 12.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.